In psoriasis, IL-17A directly enhances keratinocyte gene expression, such as that of cathelicidin (LL-37) antimicrobial peptides [94], via its target receptors, IL-17RA and IL-17RC [95]. The gene discussed is IL17A; the disease is psoriasis.